Payments to Healthcare Professionals

Payments to Healthcare Professionals

Collaboration between the pharmaceutical industry and Healthcare Professionals (HCPs) or Healthcare Organizations (HCOs) benefits patients. It is a relationship that has delivered numerous break-through medicines and changed the way many diseases impact patients’ lives. Our work together includes a range of activities from clinical research to sharing best clinical practice. As an industry we make payments or ‘transfers of value’ to Healthcare Professionals and Organizations to compensate them for the time spent working with us.

Bringing greater transparency to this already well-regulated relationship builds understanding of this collaboration and addresses public concerns about interactions between the medical community and the pharmaceutical industry. We believe that openly communicating payments helps foster trust with patients, Healthcare Professionals, government officials and the public, and supports our overall commitment to data transparency and high ethical business standards. Novartis has long been dedicated to improving clinical trial data transparency and discloses relationships with patient organizations.

In several countries, we publish payments to Healthcare Professionals and Organizations in line with local laws or regulations.

About our Reporting Practices

Europe

Across Europe, Novartis discloses annually payments and other transfers of value in line with the European Federation of Pharmaceutical Industries and Associations (EFPIA) Disclosure Code and its local transpositions. The EFPIA Disclosure Code 2024 Self-Certification Letter (PDF 0.4 MB) signed by Patrick Horber, Novartis President, International, confirms the application of the principles of the EFPIA Disclosure Code. The letter from previous year is available here (PDF 0.1 MB).

Novartis also complies with the Medicines for Europe (European Generic and Biosimilar Medicines Association) Transparency Rules and Requirements, which defines disclosure rules for the generic, biosimilar and value added medicines industry.

Following the spin-off of Sandoz from Novartis in November 2023, Novartis will still be responsible for publishing the 2023 Transparency of Value (ToV) for Sandoz, covering 2023 ToV reporting. However, from 2025 onwards, only Novartis's ToV will be published. This means that any transparency and disclosure related to Sandoz for 2024 will not be included in Novartis's publications and starting from 2025, Sandoz will handle its own reporting separately.

United States

Novartis Pharmaceuticals Corporation (NPC) is required each year to submit data to the Centers for Medicare and Medicaid Services (CMS) Open Payments program (commonly known as the Sunshine Act) as an applicable manufacturer. CMS collects information about certain payments and other transfers of value from applicable manufacturers and group purchasing organizations (GPOs) to physicians and teaching hospitals. Open Payments is the federally run transparency program that collects information about these financial relationships and makes it available to the public annually through the CMS Open Payments website.

Read more about our Payments to Healthcare Professionals in the United States.

Rest of the world

In addition to the EFPIA countries and the United States, we publicly disclose payments and transfers of value in Australia, Brazil, Colombia, Canada, Israel, Japan and New Zealand. In Chile, Indonesia, Pakistan, Philippines and Saudi Arabia, transfers of value are reported to the government. In South Korea, transfers of value are gathered and shared with the Ministry of Health upon request.

All Disclosure Reports

Disclosure Report

English

Disclosure Report

Novartis

Sandoz

Disclosure Report

Novartis

French

Dutch

Sandoz

French

Dutch

Disclosure Report

Portuguese

Disclosure Report

Novartis

Sandoz

Disclosure Report

Novartis

English

French

Sandoz

English

French

Disclosure Report

Spanish

Below is the disclosure information for Cyprus in English as per EFPIA regulations. In case of questions please contact us.


2023

Novartis

Disclosure Report (PDF 0.2 MB)

Methodological Note (PDF 0.3 MB)

For 2023 Sandoz Disclosure reports, please refer to Payments to Healthcare Professionals | Sandoz

2022

Novartis

Disclosure Report (PDF 0.2 MB)

Methodological Note (PDF 0.3 MB)

Sandoz

Methodological Note (PDF 0.5 MB)

2021

Novartis

Disclosure Report (PDF 0.2 MB)

Methodological Note (PDF 0.6 MB)

Sandoz

Methodological Note (PDF 0.5 MB)

Disclosure Report

Novartis

Sandoz

Disclosure Report

Novartis

Sandoz

Disclosure Report

Estonian

For 2023 Sandoz Disclosure reports, please refer to Payments to Healthcare Professionals | Sandoz

Disclosure Report

Novartis

Sandoz

Disclosure Report

French

Disclosure Report

Novartis

Sandoz

Disclosure Report

Greek

Disclosure Report

Novartis

Sandoz

Disclosure Report

Novartis

Sandoz

Disclosure Report

English

Disclosure Report

Hebrew

Disclosure Report

Italian

For 2023 Sandoz Disclosure reports, please refer to - Codice sulla Trasparenza | Sandoz Italia

Disclosure Report

Novartis

Sandoz

Disclosure Report

Latvian

For 2023 Sandoz Disclosure reports, please refer to Payments to Healthcare Professionals | Sandoz

Disclosure Report

Lithuanian

Below is the disclosure information for Luxembourg in English as per EFPIA regulations. In case of questions please contact us.


2023

Novartis

Disclosure Report (PDF 0.2 MB)

Methodological Note (PDF 0.3 MB)

For 2023 Sandoz Disclosure reports, please refer to Payments to Healthcare Professionals | Sandoz

2022

Novartis

Disclosure Report (PDF 0.3 MB)

Methodological Note (PDF 0.3 MB)

Sandoz

Methodological Note (PDF 0.2 MB)

2021

Novartis

Disclosure Report (PDF 0.1 MB)

Methodological Note (PDF 0.6 MB)

Sandoz

Methodological Note (PDF 0.5 MB)

Below is the disclosure information for Malta in English as per EFPIA regulations. In case of questions please contact us.


2023

Novartis

Disclosure Report (PDF 0.2 MB)

Methodological Note (PDF 0.3 MB)

For 2023 Sandoz Disclosure reports, please refer to Payments to Healthcare Professionals | Sandoz

2022

Novartis

Disclosure Report (PDF 0.2 MB)

Methodological Note (PDF 0.3 MB)

Sandoz

Methodological Note (PDF 0.5 MB)

2021

Novartis

Disclosure Report (PDF 0.2 MB)

Methodological Note (PDF 0.6 MB)

Sandoz

Methodological Note (PDF 0.5 MB)

Disclosure Report

Novartis

Sandoz

Disclosure Report

English

Disclosure Report

Novartis

Sandoz

Disclosure Report

English

Disclosure Report

Polish

Disclosure Report

Portuguese

Disclosure Report

Novartis

Sandoz

Disclosure Report

Novartis

Sandoz

Disclosure Report

Novartis

Sandoz

Disclosure Report

Novartis

Disclosure Report

Novartis

Sandoz

Disclosure Report

Novartis

Sandoz

Disclosure Report

Novartis

German

French

Sandoz

German

French

Disclosure Report

Novartis

Sandoz

Disclosure Report

Novartis

Sandoz

Disclosure Report

Ukrainian

Disclosure Report

Novartis

Sandoz


Source URL: https://www.novartis.com/investors/reporting-and-transparency-hub/payments-healthcare-professionals

List of links present in page
  1. https://www.novartis.com/investors/reporting-and-transparency-hub/payments-healthcare-professionals
  2. https://www.novartis.com/clinicaltrials
  3. https://www.novartis.com/investors/reporting-and-transparency-hub/patient-organization-funding
  4. https://www.efpia.eu/relationships-code/the-efpia-code/
  5. https://www.novartis.com/sites/novartiscom/files/efpia-self-certification-scheme-2024.pdf
  6. https://www.efpia.eu/relationships-code/healthcare-professionals-hcps/
  7. https://www.novartis.com/sites/novartiscom/files/efpia-self-certification-scheme-2023.pdf
  8. https://www.cms.gov/
  9. https://www.novartis.us/corporate-responsibility/payments-hcps-hcos
  10. https://openpaymentsdata.cms.gov/search
  11. https://www.novartis.us/corporate-responsibility/payments-hcps-hcos
  12. https://www.novartis.com.au/about-us/corporate-responsibility/corporate-responsibility-australia/financial-transparency
  13. https://www.novartis.at/ueber-uns/verantwortung/transparenz-ueber-zahlungen-angehoerige-der-fachkreise
  14. https://www.sandoz.at/ueber-uns/verantwortung/transparenz-ueber-zahlungen-angehoerige-der-fachkreise
  15. https://www.novartis.be/fr/transparence-des-paiements-aux-professionnels-de-sante
  16. https://www.novartis.be/nl/transparantie-van-betalingen-aan-gezondheidszorgverleners
  17. https://www.sandoz.be/fr/transparence-des-paiements-aux-professionnels-de-sante
  18. https://www.sandoz.be/nl/transparantie-van-betalingen-aan-gezondheidszorgverleners
  19. https://www.novartis.com/our-company/contact-us/office-locations
  20. https://www.novartis.com/sites/novartiscom/files/payment-disclosure-novartis-bosnia-2023.pdf
  21. https://www.novartis.com/sites/novartiscom/files/methodological-note-novartis-bosnia-2023.pdf
  22. https://www.sandoz.com/transparency/payments-healthcare-professionals/
  23. https://www.novartis.com/sites/novartiscom/files/payment-disclosure-novartis-bosnia-2022.pdf
  24. https://www.novartis.com/sites/novartiscom/files/methodological-note-novartis-bosnia-2022.pdf
  25. https://www.novartis.com/sites/novartiscom/files/payment-disclosure-sandoz-bosnia-2022.pdf
  26. https://www.novartis.com/sites/novartiscom/files/methodological-note-sandoz-bosnia-2022.pdf
  27. https://www.novartis.com/sites/novartiscom/files/payment-disclosure-novartis-bosnia-2021.pdf
  28. https://www.novartis.com/sites/novartiscom/files/methodological-note-novartis-bosnia-2021.pdf
  29. https://www.novartis.com/sites/novartiscom/files/payment-disclosure-sandoz-bosniaherzegovina-2021.pdf
  30. https://www.novartis.com/sites/novartiscom/files/methodological-note-sandoz-bosniaherzegovina-2021.pdf
  31. https://declarasus.saude.mg.gov.br/
  32. https://www.novartis.com/bg-bg/esg/transparency
  33. https://www.sandoz.bg/za-nas/korporativna-otgovornost/prozrachnost
  34. https://www.novartis.ca/about-us/corporate-responsibility/transparency-voluntary-disclosure-payments-healthcare
  35. https://www.novartis.ca/fr/about-us/corporate-responsibility/la-transparence-divulgation-volontaire-des-paiements-aux
  36. https://www.sandoz.ca/transparency-initiative
  37. https://www.sandoz.ca/fr/initiative-transparence
  38. https://www.novartis.com/co-es/sobre-novartis/etica-e-integridad
  39. https://www.novartis.com/about/locations?field_location_business_unit_target_id=All&field_location_country_target_id=4586
  40. https://www.novartis.com/sites/novartiscom/files/payment-disclosure-novartis-croatia-2023.pdf
  41. https://www.novartis.com/sites/novartiscom/files/methodological-note-novartis-croatia-2023.pdf
  42. https://www.sandoz.com/transparency/payments-healthcare-professionals/
  43. https://www.novartis.com/sites/novartiscom/files/payment-disclosure-novartis-croatia-2022-eur.pdf
  44. https://www.novartis.com/sites/novartiscom/files/payment-disclosure-novartis-croatia-2022-hrk.pdf
  45. https://www.novartis.com/sites/novartiscom/files/methodological-note-novartis-croatia-2022.pdf
  46. https://www.novartis.com/sites/novartiscom/files/payment-disclosure-sandoz-croatia-2022-eur.pdf
  47. https://www.novartis.com/sites/novartiscom/files/payment-disclosure-sandoz-croatia-2022-hrk.pdf
  48. https://www.novartis.com/sites/novartiscom/files/methodological-note-sandoz-croatia-2022.pdf
  49. https://www.novartis.com/sites/novartiscom/files/payment-disclosure-novartis-croatia-2021.pdf
  50. https://www.novartis.com/sites/novartiscom/files/methodological-note-novartis-croatia-2021.pdf
  51. https://www.novartis.com/sites/novartiscom/files/payment-disclosure-sandoz-croatia-2021.pdf
  52. https://www.novartis.com/sites/novartiscom/files/methodological-note-croatia-imsz-2021.pdf
  53. https://www.novartis.com/about/locations?field_location_business_unit_target_id=All&field_location_country_target_id=4501
  54. https://www.novartis.com/sites/novartiscom/files/payment-disclosure-novartis-cyprus-2023.pdf
  55. https://www.novartis.com/sites/novartiscom/files/methodological-note-novartis-cyprus-2023.pdf
  56. https://www.sandoz.com/transparency/payments-healthcare-professionals/
  57. https://www.novartis.com/sites/novartiscom/files/payment-disclosure-novartis-cyprus-2022.pdf
  58. https://www.novartis.com/sites/novartiscom/files/methodological-note-cyprus-novartis-2022.pdf
  59. https://www.novartis.com/sites/novartiscom/files/methodological-note-cyprus-sandoz-2022.pdf
  60. https://www.novartis.com/sites/novartiscom/files/payment-disclosure-novartis-cyprus-2021-v2.pdf
  61. https://www.novartis.com/sites/novartiscom/files/methodological-note-cyprus-novartis-2021.pdf
  62. https://www.novartis.com/sites/novartiscom/files/methodological-note-cyprus-sandoz-2021.pdf
  63. https://www.novartis.cz/cs/transparentni-spoluprace-zverejneni
  64. https://www.sandoz.cz/doing-business-responsibly
  65. https://www.novartis.dk/om-novartis/hvem-samarbejder-vi-med#ui-id-1=0
  66. https://www.sandoz.dk/transparency-disclosure-efpia
  67. https://www.novartis.ee/koostoeoe-tervishoiutoeoetajatega
  68. https://www.sandoz.com/transparency/payments-healthcare-professionals/
  69. https://www.novartis.fi/novartis-yrityksena/yritysvastuu/yhteistyo
  70. https://www.sandoz.fi/transparency-disclosure-efpia
  71. https://www.novartis.fr/propos-de-novartis/notre-activite/transparence-des-relations
  72. https://www.novartis.de/transparenzkodex
  73. https://www.sandoz.de/ueber-uns/verantwortungsbewusste-geschaeftsfuehrung/transparenz-von-leistungen-fachkreisangehoerige
  74. https://www.novartis.gr/sustainable-development/business-ethic/disclosure-code
  75. https://www.novartis.com/hu-hu/egeszsegugyi-szakemberek/atlathatosag
  76. https://www.sandoz.hu/rolunk/felelos-uzletvitel
  77. https://frumtok.is/sidareglur/
  78. https://www.sandoz.dk/transparency-disclosure-efpia
  79. https://www.novartis.ie/ethics-and-compliance-transparency
  80. https://www.health.gov.il/Subjects/Finance/Pages/donation_reports.aspx
  81. https://www.novartis.it/su-di-noi/responsabilita-sociale/etica-persone-ambiente/codice-sulla-trasparenza
  82. https://www.sandoz.it/su-di-noi/condotta-responsabile-del-business/codice-sulla-trasparenza/
  83. https://www.novartis.com/jp-ja/esg/transparency
  84. https://www.sandoz.jp/about-us
  85. https://www.novartis.com/lv-lv/veselibas-aprupes-specialisti/sadarbiba-ar-veselibas-aprupes-specialistiem
  86. https://www.sandoz.com/transparency/payments-healthcare-professionals/
  87. https://www.novartis.com/lt-lt/sveikatos-prieziuros-specialistai/bendradarbiavimas-su-sveikatos-prieziuros-specialistais
  88. https://www.novartis.com/about/locations?field_location_business_unit_target_id=All&field_location_country_target_id=4681
  89. https://www.novartis.com/sites/novartiscom/files/payment-disclosure-novartis-luxembourg-2023.pdf
  90. https://www.novartis.com/sites/novartiscom/files/methodological-note-novartis-luxembourg-2023.pdf
  91. https://www.sandoz.com/transparency/payments-healthcare-professionals/
  92. https://www.novartis.com/sites/novartiscom/files/payment-disclosure-novartis-luxembourg-2022.pdf
  93. https://www.novartis.com/sites/novartiscom/files/methodological-note-luxembourg-novartis-2022.pdf
  94. https://www.novartis.com/sites/novartiscom/files/methodological-note-luxembourg-sandoz-2022.pdf
  95. https://www.novartis.com/sites/novartiscom/files/payment-disclosure-novartis-luxembourg-2021.pdf
  96. https://www.novartis.com/sites/novartiscom/files/methodological-note-luxembourg-novartis-2021.pdf
  97. https://www.novartis.com/sites/novartiscom/files/methodological-note-luxembourg-sandoz-2021.pdf
  98. https://www.novartis.com/about/locations?field_location_business_unit_target_id=All&field_location_country_target_id=4706
  99. https://www.novartis.com/sites/novartiscom/files/payment-disclosure-novartis-malta-2023.pdf
  100. https://www.novartis.com/sites/novartiscom/files/methodological-note-novartis-malta-2023.pdf
  101. https://www.sandoz.com/transparency/payments-healthcare-professionals/
  102. https://www.novartis.com/sites/novartiscom/files/payment-disclosure-novartis-malta-2022.pdf
  103. https://www.novartis.com/sites/novartiscom/files/methodological-note-malta-novartis-2022.pdf
  104. https://www.novartis.com/sites/novartiscom/files/methodological-note-malta-sandoz-2022.pdf
  105. https://www.novartis.com/sites/novartiscom/files/payment-disclosure-novartis-malta-2021.pdf
  106. https://www.novartis.com/sites/novartiscom/files/methodological-note-malta-novartis-2021.pdf
  107. https://www.novartis.com/sites/novartiscom/files/methodological-note-malta-sandoz-2021.pdf
  108. https://www.novartis.nl/transparantie-nederland
  109. https://www.sandoz.nl/over-ons/verantwoord-zakendoen
  110. https://www.novartis.com.au/about-us/corporate-responsibility/corporate-responsibility-australia-new-zealand/financial-transparency-for-new-zealand
  111. https://www.novartis.com/about/locations?field_location_business_unit_target_id=All&field_location_country_target_id=4701
  112. https://www.novartis.com/sites/novartiscom/files/payment-disclosure-novartis-north-macedonia-2023.pdf
  113. https://www.novartis.com/sites/novartiscom/files/methodological-note-novartis-north-macedonia-2023.pdf
  114. https://www.sandoz.com/transparency/payments-healthcare-professionals/
  115. https://www.novartis.com/sites/novartiscom/files/payment-disclosure-novartis-north-macedonia-2022.pdf
  116. https://www.novartis.com/sites/novartiscom/files/methodological-note-novartis-northmacedonia-2022.pdf
  117. https://www.novartis.com/sites/novartiscom/files/payment-disclosure-sandoz-northmacedonia-2022.pdf
  118. https://www.novartis.com/sites/novartiscom/files/methodological-note-sandoz-north-macedonia-2022.pdf
  119. https://www.novartis.com/sites/novartiscom/files/payment-disclosure-novartis-macedonia-2021.pdf
  120. https://www.novartis.com/sites/novartiscom/files/methodological-note-novartis-macedonia-2021.pdf
  121. https://www.novartis.com/sites/novartis_com/files/payment-disclosure-sandoz-north-macedonia-2021.pdf
  122. https://www.novartis.com/sites/novartis_com/files/methodological-note-sandoz-north-macedonia-2021.pdf
  123. https://www.novartis.com/no-no/om-oss/pengeoverforing-til-helsetjenesten
  124. https://www.sandoz.no/transparency-disclosure-efpia
  125. https://www.novartis.com/ph-en/esg/financial-transparency-philippines
  126. https://www.novartis.pl/wspolpraca-z-przedstawicielami-zawodow-medycznych-oraz-organizacjami-ochrony-zdrowia#ui-id-1=0
  127. https://www.novartis.pt/transferencias-de-valor-profissionais-e-organizacoes-de-saude
  128. https://www.novartis.com.ro/contributia-noastra/transparenta
  129. https://www.sandoz.ro/despre-noi/etica-si-conformitate
  130. https://www.novartis.ru/about-us/corporate-responsibility/general-disclosure
  131. https://www.sandoz.ru/o-kompanii/otvetstvennoe-vedenie-biznesa/general-disclosure
  132. https://www.novartis.com/about/locations?field_location_business_unit_target_id=All&field_location_country_target_id=4801
  133. https://www.novartis.com/sites/novartiscom/files/payment-disclosure-novartis-serbia-2023.pdf
  134. https://www.novartis.com/sites/novartiscom/files/methodological-note-novartis-serbia-2023.pdf
  135. https://www.novartis.com/sites/novartiscom/files/payment-disclosure-sandoz-serbia-2023.pdf
  136. https://www.novartis.com/sites/novartiscom/files/methodological-note-sandoz-serbia-2023.pdf
  137. https://www.novartis.com/sites/novartiscom/files/payment-disclosure-novartis-serbia-2022.pdf
  138. https://www.novartis.com/sites/novartiscom/files/methodological-note-novartis-serbia-2022.pdf
  139. https://www.novartis.com/sites/novartiscom/files/payment-disclosure-sandoz-serbia-2022.pdf
  140. https://www.novartis.com/sites/novartiscom/files/methodological-note-sandoz-serbia-2022.pdf
  141. https://www.novartis.com/sites/novartiscom/files/payment-disclosure-novartis-serbia-2021.pdf
  142. https://www.novartis.com/sites/novartiscom/files/methodological-note-novartis-serbia-2021.pdf
  143. https://www.novartis.com/sites/novartiscom/files/payment-disclosure-sandoz-serbia-2021.pdf
  144. https://www.novartis.com/sites/novartiscom/files/methodological-note-sandoz-serbia-2021.pdf
  145. https://www.novartis.sk/o-nas/spolocenska-zodpovednost/transparentnost-v-platbach-zdravotnickym-pracovnikom
  146. https://www.sandoz.sk/o-nas/transparentna-spolupraca
  147. https://www.novartis.com/about/locations?field_location_business_unit_target_id=All&field_location_country_target_id=4826
  148. https://www.novartis.com/sites/novartiscom/files/payment-disclosure-novartis-slovenia-2023.pdf
  149. https://www.novartis.com/sites/novartiscom/files/methodological-note-novartis-slovenia-2023.pdf
  150. https://www.sandoz.com/transparency/payments-healthcare-professionals/
  151. https://www.novartis.com/sites/novartiscom/files/payment-disclosure-novartis-slovenia-2022.pdf
  152. https://www.novartis.com/sites/novartiscom/files/methodological-note-novartis-slovenia-2022.pdf
  153. https://www.novartis.com/sites/novartiscom/files/payment-disclosure-sandoz-slovenia-2022.pdf
  154. https://www.novartis.com/sites/novartiscom/files/methodological-note-sandoz-slovenia-2022.pdf
  155. https://www.novartis.com/sites/novartiscom/files/payment-disclosure-novartis-slovenia-2021.pdf
  156. https://www.novartis.com/sites/novartiscom/files/methodological-note-novartis-slovenia-2021.pdf
  157. https://www.novartis.com/sites/novartiscom/files/payment-disclosure-sandoz-slovenia-2021.pdf
  158. https://www.novartis.com/sites/novartiscom/files/methodological-note-novartis-slovenia-2021.pdf
  159. https://www.novartis.com/kr-ko/esg/corporate-responsibility/doing-business-responsibility
  160. https://www.novartis.es/sobre-novartis/responsabilidad-social/practica-empresarial-responsable/transparencia-en-las
  161. https://www.sandozfarma.es/sobre-sandoz/responsabilidad-social-corporativa/practica-empresarial-responsable/transferencias-de
  162. https://www.novartis.se/om-novartis/vart-ansvar/transparent-samarbete
  163. https://www.sandoz.se/transparency-disclosure-efpia
  164. https://www.novartis.ch/offenlegung
  165. https://www.novartis.com/ch-fr/societe-environnement/publication-des-transferts-de-valeurs
  166. https://www.sandoz-pharmaceuticals.ch/de/ueber-uns/verantwortungsvolle-geschaeftsfuehrung/offenlegung-der-geldwerten-leistungen-fachpersonen
  167. https://www.sandoz-pharmaceuticals.ch/fr/ueber-uns/verantwortungsvolle-geschaeftsfuehrung/publication-des-transferts-des-valeurs-aux
  168. https://www.novartis.com.tr/hakkimizda/kurumsal-sorumluluk
  169. https://www.sandoz.com.tr/hakkimizda/yapma-sorumlulugumuz
  170. https://www.novartis.com/uk-en/esg/transparency/healthcare-professional-payment-transparency
  171. https://www.sandoz.uk.com/about-us/transparency/
  172. https://aprad.org.ua/tematichni-rozdili/rozkrittya-informatsiyi/
  173. https://www.pharma.us.novartis.com/corporate-responsibility/physician-payments-sunshine-act
  174. https://www.us.sandoz.com/about-us/doing-business-responsibly